Crossover and double blind study with metformin and rosiglitazone in impaired glucose tolerance subjects.
Flores-Saenz
Jose Luis
JL
Programa de Doctorado en Ciencias Biológicas, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana Unidad Iztapalapa, México, D.F. joseluis_7508@terra.com.mx
Trujillo-Arriaga
Hector Miguel
HM
Rivas-Vilchis
Jose Federico
JF
Mendez-Francisco
Jose Domingo
JD
Alarcon-Aguilar
Francisco Javier
FJ
Roman-Ramos
Ruben
R
D000328:Adult; D019540:Area Under Curve; D001786:Blood Glucose / Q000378:metabolism; D008076:Cholesterol, HDL / Q000097:blood; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D018149:Glucose Intolerance / Q000188:drug therapy*; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008076:Cholesterol, HDL; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin; D000077154:Rosiglitazone; D045162:Thiazolidinediones; D014280:Triglycerides